HealthVerity IPGE changes the world for researchers
The Inside Story Behind MOM, the Maternal Outcomes Masterset In the Spring of 2021, HealthVerity...
Regulatory decision-making depends on evidence that reflects how medical products perform in real-world use, not only in controlled trials. For more than a decade, the Food and Drug Administration has relied on real-world data and real-world...
The Inside Story Behind MOM, the Maternal Outcomes Masterset In the Spring of 2021, HealthVerity...
Written by Emery Niemiec I recently attended the 2022 INFORMS Business Analytics Conference and had...
Exploring the impacts and benefits of a real-world data strategy for long-term care insurance...
Why government and public health agencies contract for the HealthVerity IPGE platform as a trusted...
In the first installment of our HealthVerity IPGE blog series covering the four foundational...
How real-world data (RWD) from open and closed claims and beyond can be layered to better explore...
Patient Identity Resolution: The next era of healthcare data interoperability The HealthVerity...
The intrinsic role of real-world data to help determine the necessity for booster shots as new...
In a recent HealthVerity LIVE webinar, we took an in-depth look at how the HealthVerity IPGE...
COVID-19 urgently highlighted the need for real-time data, and with it, the need to tap into a...
RWE and HEOR teams face increasing pressure to produce evidence that holds up beyond internal analysis. As real-world data informs decisions subject to external review, expectations for data quality have changed.